Mail Icon info@synchemia.com | sales@synchemia.com Phone Icon 9766925136
We are thrilled to announce that the highly anticipated N-Nitroso impurities of Amide and Indole have now been successfully developed e.g. N-Nitroso Orlistat , N-Nitroso Ropinirole , N-Nitroso Caprolactam ,N-Nitroso Gabapentin EP Impurity A , N-Nitroso Rizatriptan , N-Nitroso Zolmitriptan, N-Nitroso Naratriptan , N-Nitroso Tadalafil , N-Nitroso Eletriptan etc. are ready Stock
search icon
Mail Icon info@synchemia.com | sales@synchemia.com Phone Icon 9766925136
We are thrilled to announce that the highly anticipated N-Nitroso impurities of Amide and Indole have now been successfully developed e.g. N-Nitroso Orlistat , N-Nitroso Ropinirole , N-Nitroso Caprolactam ,N-Nitroso Gabapentin EP Impurity A , N-Nitroso Rizatriptan , N-Nitroso Zolmitriptan, N-Nitroso Naratriptan , N-Nitroso Tadalafil , N-Nitroso Eletriptan etc. are ready Stock

Menu

search icon
home icon Home > API Impurities > Deucravacitinib > Deucravacitinib Impurity 11

Deucravacitinib Impurity 11

Chemical Structure
Specifications
Product name
Deucravacitinib Impurity 11
SRC CAT No
SRC-D3492
CAS No
NA
Mol.F.
C5H3N2O4 : Na
Mol.Wt.
155.1 : 23.0g/mole
Related CAS No.
1442437-21-9 (free base) ; 2328068-84-2 (HCl salt)
Inv Status
CUSTOM SYNTHESIS
Chemical Structure
Chemical Structure
view file icon VIEW COA
Product Overview
Description
Chemical Name
Sodium 4-hydroxy-6-oxo-1,6-dihydropyridazine-3-carboxylate

HSN Code
38229010
Synonym
N.A

Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compound.Deucravacitinib is used to treat moderate to severe plaque psoriasis, which is a skin disease with red patches and white scales that do not go away. It is given to patients who may receive other types of treatment, including pills, injection, or phototherapy (light treatment).

Deucravacitinib Impurity 11 CAS NO: NA chemically represented as Sodium 4-hydroxy-6-oxo-1,6-dihydropyridazine-3-carboxylate.Synchemia is the leading manufacturing and exporter of Deucravacitinib Impurity 11. We supply Deucravacitinib Impurity 11 with detailed characterization data compliance with regulatory guidelines.